Table 2 Median values of clinical variables in the QUEST-RA study by country
CountryESRSJC280–28TJC280–28LIM280–28MDGlobal0–10HAQ0–3MDHAQ0–3Pain0–10Global0–10Fatigue0–10DAS280–10%am15*
Denmark14.01.02.00.01.30.630.502.62.83.63.356%
Finland13.01.01.00.00.90.630.502.82.82.63.166%
France16.01.02.01.02.50.880.603.93.64.23.660%
Germany20.03.04.00.03.00.750.605.04.94.64.356%
Ireland18.03.04.02.01.60.750.703.42.93.54.055%
Italy28.02.04.00.03.01.060.804.95.04.94.551%
The Netherlands15.01.00.01.00.60.750.602.52.73.13.049%
Poland31.06.09.03.04.31.381.205.04.85.25.378%
Spain17.01.01.00.01.20.880.723.23.63.73.547%
Sweden19.02.02.01.01.30.880.703.33.33.73.667%
UK21.01.04.00.02.00.880.704.23.85.14.265%
Turkey30.00.02.50.02.00.880.704.24.64.54.153%
Serbia28.06.018.02.04.61.631.405.15.35.56.171%
USA14.02.01.00.01.90.630.563.32.63.23.258%
Argentina30.09.010.52.04.61.000.905.04.76.35.664%
Total21.02.03.01.02.20.880.704.04.04.44.061%
  • DAS28, disease activity score on 28-joint count; ESR, erythrocyte sedimentation rate; HAQ, Health Assessment Questionnaire; LIM, limited motion/deformity joint count; MDGlobal, Doctor Global Assessment of Disease Activity; MDHAQ, multidimensional HAQ; QUEST-RA, Quantitative Patient Questionnaires in Standard Monitoring of Patients with Rheumatoid Arthritis; SJC, swollen joint count; TJC, tender joint count.

  • *Percentage of patients who report morning stiffness of 15 min or more.

  • A file including the interquartile ranges of variables is provided in the supplementary material.